Durham, NC, United States of America

Johann Jakob Leban

This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johann Jakob Leban. Retrieved from https://idiyas.com/inventor/johann-jakob-leban

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Johann Jakob Leban: Innovator in Pharmaceutical Compounds

Introduction

Johann Jakob Leban is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative compounds that have the potential to impact medical treatments.

Latest Patents

Leban's latest patents include advancements in pharmaceutical compounds and neuropeptide Y antagonists. The first patent provides a compound of formula (I) or a salt thereof, which showcases his expertise in creating effective pharmaceutical solutions. The second patent focuses on neuropeptide Y antagonists, further demonstrating his commitment to advancing medical science.

Career Highlights

Throughout his career, Johann Jakob Leban has been associated with Glaxo Wellcome Inc., a prominent company in the pharmaceutical industry. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Leban has worked alongside notable colleagues such as Andreas Spaltenstein and Douglas Byron Sherman. These collaborations have enriched his research and led to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Johann Jakob Leban is a distinguished inventor whose work in pharmaceutical compounds and neuropeptide Y antagonists has made a significant impact in the field. His contributions continue to influence medical advancements and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…